A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf in Stable Liver Transplantation Patients and a Pharmacokinetics Study.

Trial Profile

A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf in Stable Liver Transplantation Patients and a Pharmacokinetics Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 11 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Mar 2009 Actual patient number (172) added as reported by ClinicalTrials.gov.
    • 10 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top